WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/007870    International Application No.:    PCT/IB2002/001609
Publication Date: 30.01.2003 International Filing Date: 10.05.2002
Chapter 2 Demand Filed:    31.01.2003    
C07D 263/20 (2006.01), C07D 413/10 (2006.01), C07D 413/12 (2006.01), C07D 413/14 (2006.01)
Applicants: RANBAXY LABORATORIES LIMITED [IN/IN]; 19, Nehru Place, New Delhi 110 019, Delhi (IN) (For All Designated States Except US).
MEHTA, Anita [IN/IN]; (IN) (For US Only).
ARORA, Sudershan, K. [IN/IN]; (IN) (For US Only).
DAS, Biswajit [IN/IN]; (IN) (For US Only).
RAY, Abhijit [IN/US]; (US) (For US Only).
RUDRA, Sonali [IN/IN]; (IN) (For US Only).
RATTAN, Ashok [IN/IN]; (IN) (For US Only)
Inventors: MEHTA, Anita; (IN).
ARORA, Sudershan, K.; (IN).
DAS, Biswajit; (IN).
RAY, Abhijit; (US).
RUDRA, Sonali; (IN).
RATTAN, Ashok; (IN)
Agent: DESHMUKH, Jayadeep R.; Ranbaxy Laboratories Limited, 600 College Road East, Suite 2100, Princeton, NJ 08540 (US)
Priority Data:
PCT/IB01/01262 16.07.2001 IB
Abstract: front page image
(EN)The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharma-ceutical compositions containing the compounds of the present invention as anti-microbials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria such as multiply-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms such as Bacterioides spp. and Clostridia spp. species, and acid fast organisms such as Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.
(FR)La présente invention concerne certains oxazolidones de phényle substitués et des procédés de synthèse de ces derniers. L'invention a aussi pour objet des compositions pharmaceutiques contenant les composés selon l'invention comme antimicrobiens. Ces composés présentent une grande utilité comme agents antimicrobiens, sont efficaces pour lutter contre un certain nombre d'agents pathogènes humains et vétérinaires, y compris des bactéries aérobies gram-positives comme les staphylocoques, les streptocoques et les entérocoques polyrésistants ainsi que des organismes anaérobies comme les espèces Bactérioides et Clostidria, et des organismes acido-résistants comme les espèces Mycobacterium tuberculosis avium et Mycobacterium.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)